Corpus Uteri Cancer clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study
Sorry, not yet accepting patients
The purpose of the study is to characterize baseline multidisciplinary tumor board (MDTB) context and variability, evaluate the relationship between baseline fitness of patients with cancer and initial treatment recommendations, and assess the impact of the INSPIRE intervention, which involves including electronic patient reported outcomes (ePROs) within MDTB on MDTB discussion content, provider burden, treatment recommended and received, healthcare utilization, and patient-reported outcomes.
Los Angeles, California and other locations
Our lead scientists for Corpus Uteri Cancer research studies include Mina Sedrak, MD.
Last updated: